National Psoriasis Foundation

Drug Pipeline

« Back to the pipeline

Company

Biotest/AbbVie

Therapeutic Approach

Injectables

Indication

Psoriasis

Mechanism

immune suppressant (anti-CD4 antibody; activates regulatory T cells)

Phase

Phase II

Get the latest research news and tips on managing your psoriasis and psoriatic arthritis.